(VIANEWS) – Canadian Pacific Railway (CP), Merit Medical Systems (MMSI), Erie Indemnity Company (ERIE) are the highest sales growth and return on equity stocks on this list.
Here is a list of stocks with an above 5% expected next quarter sales growth, and a 3% or higher return on equity. May these stocks be a good medium-term investment option?
1. Canadian Pacific Railway (CP)
56.3% sales growth and 10.14% return on equity
Canadian Pacific Kansas City Limited, together with its subsidiaries, owns and operates a transcontinental freight railway in Canada and the United States. The company transports bulk commodities, including grain, coal, potash, fertilizers, and sulphur; and merchandise freight, such as energy, chemicals and plastics, metals, minerals and consumer, automotive, and forest products. It transports intermodal traffic comprising retail goods in overseas containers. The company offers rail and intermodal transportation services through a network of approximately 13,000 miles serving business centers in Quebec and British Columbia, Canada; and the United States Northeast and Midwest regions. Canadian Pacific Kansas City Limited is headquartered in Calgary, Canada.
Earnings Per Share
As for profitability, Canadian Pacific Railway has a trailing twelve months EPS of $3.04.
PE Ratio
Canadian Pacific Railway has a trailing twelve months price to earnings ratio of 26.25. Meaning, the purchaser of the share is investing $26.25 for every dollar of annual earnings.
The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 10.14%.
Earnings Before Interest, Taxes, Depreciation, and Amortization
Canadian Pacific Railway’s EBITDA is 64.1.
Yearly Top and Bottom Value
Canadian Pacific Railway’s stock is valued at $79.81 at 20:22 EST, below its 52-week high of $83.45 and way higher than its 52-week low of $65.17.
2. Merit Medical Systems (MMSI)
12.4% sales growth and 7.6% return on equity
Merit Medical Systems, Inc. manufactures and markets disposable medical devices for interventional, diagnostic, and therapeutic procedures in cardiology, radiology, oncology, critical care, and endoscopy. The company operates in two segments, Cardiovascular and Endoscopy. It provides peripheral intervention products for the diagnosis and treatment of diseases in peripheral vessels and organs; and cardiac intervention products, such as access, angiography, hemostasis, intervention, fluid management, electrophysiology and cardiac rhythm management, and hemodynamic monitoring to treat various heart conditions. The company also offers custom procedural solutions that include critical care products, disinfection protection systems, syringes, swab and collection systems, manifold kits, and trays and packs; coated tubes and wires; and sensor components for microelectromechanical systems. In addition, it provides pulmonary products that consist of laser-cut tracheobronchial stents, advanced over-the-wire and direct visualization delivery systems, and dilation balloons; gastroenterology products; and kits and accessories for endoscopy and bronchoscopy procedures. The company sells its products to hospitals and alternate site-based physicians, technicians, and nurses through direct sales force, distributors, original equipment manufacturer partners, or custom procedure tray manufacturers in the United States and internationally. The company was incorporated in 1987 and is headquartered in South Jordan, Utah.
Earnings Per Share
As for profitability, Merit Medical Systems has a trailing twelve months EPS of $1.48.
PE Ratio
Merit Medical Systems has a trailing twelve months price to earnings ratio of 56.51. Meaning, the purchaser of the share is investing $56.51 for every dollar of annual earnings.
The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 7.6%.
Growth Estimates Quarters
The company’s growth estimates for the current quarter and the next is 2.7% and 9.4%, respectively.
Volume
Today’s last reported volume for Merit Medical Systems is 369226 which is 35.67% above its average volume of 272137.
3. Erie Indemnity Company (ERIE)
9.9% sales growth and 22.42% return on equity
Erie Indemnity Company operates as a managing attorney-in-fact for the subscribers at the Erie Insurance Exchange in the United States. The company provides sales, underwriting, policy issuance, and renewal services for the policyholders on behalf of the Erie Insurance Exchange. It also offers sales related services, including agent compensation, and sales and advertising support services; and underwriting services comprise underwriting and policy processing; and other services consist of customer services and administrative support services, as well as information technology services. Erie Indemnity Company was incorporated in 1925 and is based in Erie, Pennsylvania.
Earnings Per Share
As for profitability, Erie Indemnity Company has a trailing twelve months EPS of $6.06.
PE Ratio
Erie Indemnity Company has a trailing twelve months price to earnings ratio of 34.36. Meaning, the purchaser of the share is investing $34.36 for every dollar of annual earnings.
The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 22.42%.
Revenue Growth
Year-on-year quarterly revenue growth grew by 12%, now sitting on 2.92B for the twelve trailing months.
4. Cisco (CSCO)
9.7% sales growth and 27.74% return on equity
Cisco Systems, Inc. designs, manufactures, and sells Internet Protocol based networking and other products related to the communications and information technology industry in the Americas, Europe, the Middle East, Africa, the Asia Pacific, Japan, and China. The company also offers switching portfolio encompasses campus switching as well as data center switching; enterprise routing portfolio interconnects public and private wireline and mobile networks, delivering highly secure, and reliable connectivity to campus, data center and branch networks; wireless products include wireless access points that are standalone, controller appliance-based, switch-converged, and Meraki cloud-managed offerings; and compute portfolio including the cisco unified computing system, hyperflex, and software management capabilities, which combine computing, networking, and storage infrastructure management and virtualization. In addition, it provides Internet for the future product consists of routed optical networking, 5G, silicon, and optics solutions; collaboration products, such as meetings, collaboration devices, calling, contact center, and communication platform as a service; end-to-end security product consists of network security, cloud security, security endpoints, unified threat management, and zero trust; and optimized application experiences products including full stack observability and cloud-native platform. Further, the company offers a range of service and support options for its customers, including technical support and advanced services and advisory services. It serves businesses of various sizes, public institutions, governments, and service providers. The company sells its products and services directly, as well as through systems integrators, service providers, other resellers, and distributors. Cisco Systems, Inc. has strategic alliances with other companies. Cisco Systems, Inc. was incorporated in 1984 and is headquartered in San Jose, California.
Earnings Per Share
As for profitability, Cisco has a trailing twelve months EPS of $2.79.
PE Ratio
Cisco has a trailing twelve months price to earnings ratio of 18.32. Meaning, the purchaser of the share is investing $18.32 for every dollar of annual earnings.
The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 27.74%.
Sales Growth
Cisco’s sales growth is 14.9% for the present quarter and 9.7% for the next.
Dividend Yield
As maintained by Morningstar, Inc., the next dividend payment is on Jul 4, 2023, the estimated forward annual dividend rate is 1.56 and the estimated forward annual dividend yield is 3.06%.
Growth Estimates Quarters
The company’s growth estimates for the present quarter and the next is 27.7% and 15.1%, respectively.
Previous days news about Cisco(CSCO)
- According to Zacks on Tuesday, 18 July, "In the second quarter, AT&T collaborated with Cisco to launch innovative solutions that enhance connectivity and advance the calling landscape for hybrid workforces. "
5. Ingredion Incorporated (INGR)
8% sales growth and 16.78% return on equity
Ingredion Incorporated, together with its subsidiaries, produces and sells starches and sweeteners for various industries. It operates through four segments: North America; South America; Asia Pacific; and Europe, Middle East, and Africa. The company offers sweetener products comprising glucose syrups, high maltose syrups, high fructose corn syrups, caramel colors, dextrose, polyols, maltodextrins, glucose and syrup solids, as well as food-grade and industrial starches, biomaterials, and nutrition ingredients. It also provides animal feed products; edible corn oil; refined corn oil to packers of cooking oil and to producers of margarine, salad dressings, shortening, mayonnaise, and other foods; and corn gluten feed used as protein feed for chickens, pet food, and aquaculture. The company's products are derived primarily from processing corn and other starch-based materials, such as tapioca, potato, and rice. It serves food, beverage, paper and corrugating products, brewing, pharmaceutical, textile, and personal care industries, as well as animal feed markets. The company was formerly known as Corn Products International, Inc. and changed its name to Ingredion Incorporated in June 2012. Ingredion Incorporated was founded in 1906 and is headquartered in Westchester, Illinois.
Earnings Per Share
As for profitability, Ingredion Incorporated has a trailing twelve months EPS of $8.21.
PE Ratio
Ingredion Incorporated has a trailing twelve months price to earnings ratio of 13.33. Meaning, the purchaser of the share is investing $13.33 for every dollar of annual earnings.
The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 16.78%.
6. National Retail Properties (NNN)
6.7% sales growth and 8.55% return on equity
National Retail Properties invests primarily in high-quality retail properties subject generally to long-term, net leases. As of June 30, 2020, the company owned 3,117 properties in 48 states with a gross leasable area of approximately 32.5 million square feet and with a weighted average remaining lease term of 10.9 years.
Earnings Per Share
As for profitability, National Retail Properties has a trailing twelve months EPS of $1.93.
PE Ratio
National Retail Properties has a trailing twelve months price to earnings ratio of 22.41. Meaning, the purchaser of the share is investing $22.41 for every dollar of annual earnings.
The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 8.55%.
